Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2005
11/22/2005US6967243 Hybrid rape oil; genetic engineering
11/22/2005US6967237 For use in stimulating growth hormone secretion
11/22/2005US6967108 use of human monoclonal antibodies in a method for detecting antibodies to IA-2, a method for detecting antibodies to the islet cell antigen IA-2 and a method for detecting the islet cell antigen IA-2 in a sample
11/22/2005US6967097 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of viral diseases
11/22/2005US6967095 DNA sequence encoding human secretory type PLA2 protein (IID type) from human spleen cDNA library
11/22/2005US6967094 Peptide for use in treatment of cancer, parkinson's and metabolic disorders
11/22/2005US6967093 Glycosyl sulfotransferase-3
11/22/2005US6967092 Multi-functional chimeric hematopoietic receptor agonists
11/22/2005US6967090 Nucleic acid and protein sequences of bovine epidermal growth factor
11/22/2005US6967089 Delivery system for porcine somatotropin
11/22/2005US6967080 mapping one or more epitopes of the protein and altering the amino acid sequence of one or more epitopes of the protein in order to make the protein less immunogenic.
11/22/2005US6967079 Pyrimidine derivatives for labeled binding partners
11/22/2005US6967078 nuclear transcriptional regulation following BMP signal transduction; screening for a compound that disrupts transcriptional repression of a gene
11/22/2005US6967077 Methods and compositions for regulating T cell subsets by modulating transcription factor activity
11/22/2005US6967076 A reporter sequence consists of a reporter gene whose expression is regulated by a protein specific to HIV viruses, expressed from a genome of an HIV virus upon infection of a cell tranduced by genetic engineered viral vector
11/22/2005US6967019 Production of pancreatic islet cells and delivery of insulin
11/22/2005US6967018 Adiponectin gene therapy
11/22/2005US6967016 Method of determining therapeutic activity and/or possible side-effects of a medicament
11/22/2005CA2267639C Synthetic hpv16 virus-like particles
11/22/2005CA2174081C Membrane protein polypeptide having function of supporting pre-b cell growth and gene therefor
11/22/2005CA2137559C Maintenance of male-sterile plants
11/22/2005CA2068066C Herpesvirus particles and vaccine
11/18/2005CA2505688A1 Herbicidal compound resistant plant
11/17/2005WO2005108622A2 Methods and kits to increase the efficiency of oligonucleotide-directed nucleic acid sequence alteration
11/17/2005WO2005108620A2 Processing polynucleotide-containing samples
11/17/2005WO2005108617A2 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
11/17/2005WO2005108602A1 Method for the isolation of specific molecules which bind in a highly selective manner to selected target molecules
11/17/2005WO2005108592A1 Process for production of optically active propargyl alcohol
11/17/2005WO2005108589A1 Cell preparation
11/17/2005WO2005108588A1 Novel hiv-based recombinant viral clones and use thereof in analytical methods
11/17/2005WO2005108587A1 Regulatory sequence for the expression of a gene in the axillary meristems of plants and applications thereof
11/17/2005WO2005108586A1 A method for increasing the ratio of homologous to non-homologous recombination
11/17/2005WO2005108585A1 Preparation method for the production of active and soluble proteins in prokaryotes and polycistronic vectors therefor
11/17/2005WO2005108584A1 Recombinant chemokine-antigen vaccine
11/17/2005WO2005108582A1 DETECTING DISEASE ASSOCIATION WITH ABERRANT GLYCOGEN SYNTHASE KINASE 3β EXPRESSION
11/17/2005WO2005108581A1 Recombinant virus vector for gene introduction in lymphocyte
11/17/2005WO2005108579A1 Polynucleotides for the detection of staphylococcus aureus
11/17/2005WO2005108578A1 Polynucleotides for the detection of escherichia coli
11/17/2005WO2005108577A1 Plant cad1-like genes and their use
11/17/2005WO2005108575A1 T-type calcium channel splice variant compositions and methods
11/17/2005WO2005108574A1 Gm1 PROMOTER AND USE THEREOF
11/17/2005WO2005108573A2 Method to induce rnai in prokaryotic organisms
11/17/2005WO2005108572A1 Compounds and method for immunosuppression
11/17/2005WO2005108571A1 Micro-reactor for testing, genetic testing apparatus, and genetic testing method
11/17/2005WO2005108570A1 Nucleic acid/enzyme complex
11/17/2005WO2005108569A1 Method of determining breed of pig
11/17/2005WO2005108568A1 Methods for assembling multiple expression constructs
11/17/2005WO2005108567A1 Method of constructing modified protein
11/17/2005WO2005108564A2 Production of peptides in plants as viral coat protein fusion
11/17/2005WO2005108552A1 Mutant saccharomyces cerevisiae strain utilizing xylose for ethanol production
11/17/2005WO2005108422A2 Ammonium/ammonia transporter
11/17/2005WO2005108421A1 Crystal structure of human proliferating cell nuclear antigen (pcna) and uses thereof
11/17/2005WO2005108420A1 Cancer associated antigens
11/17/2005WO2005107817A2 Medical device with coating for capturing genetically-altered cells and methods of using same
11/17/2005WO2005107816A2 Methods and compositions for reducing viral genome amounts in a target cell
11/17/2005WO2005107796A2 Cellular permissivity factor for viruses, and uses thereof
11/17/2005WO2005107790A1 Hybrid recombinases for genome manipulation
11/17/2005WO2005107474A2 Oncolytic adenovirus armed with therapeutic genes
11/17/2005WO2005107447A2 Methods for the production of improved live stocks and disease models for therapeutic research
11/17/2005WO2005107437A2 Novel herbicide resistance genes
11/17/2005WO2005082931B1 Novel phytochrome-interacting protein and a use thereof
11/17/2005WO2005077423A3 Adept or gdept producing acetaldehyde
11/17/2005WO2005075656A8 Biochip electroporator and its use in multi-site, single-cell electroporation
11/17/2005WO2005071089A3 Dual host expression vector system and screening methods
11/17/2005WO2005066208A3 Method for production of recombinant growth hormone in form of hybrid protein
11/17/2005WO2005061702A3 Plants having increased yield and method for making the same
11/17/2005WO2005058020A3 Generation of plants with altered oil content
11/17/2005WO2005049644A3 Tool for the transfer and production of proteins using the pseudomonas type iii secretion system
11/17/2005WO2005046622A3 Custom vectors for treating and preventing pancreatic cancer
11/17/2005WO2005039643A3 In vivo gene therapy of parkinson's disease
11/17/2005WO2005037988A3 Nucleic acid-adsorbing porous membrane for separating and purifying nucleic acid and apparatus for separating and purifying nucleic acid
11/17/2005WO2005030122A3 Inactivated host cell delivery of polynucleotides encoding immunogens
11/17/2005WO2005026331A3 Method of preparation of pharmaceutically grade plasmid dna
11/17/2005WO2005021577A3 Novel plant glycine and histidinie-rich metal-binding protein family and uses thereof
11/17/2005WO2005021044A3 Nanoparticles for delivery of nucleic acids and stable double-stranded rna
11/17/2005WO2005020972A3 Combination therapy for the treatment of ocular neovascular disorders
11/17/2005WO2005012515A3 Novel glyphosate-n-acetyltransferase (gat) genes
11/17/2005WO2005000234A3 Novel coronavirus inhibitors
11/17/2005WO2004108945A3 Oligonucleotide modulation of cell adhesion
11/17/2005WO2004103316A3 Orp9, a novel therapeutic target for increasing hdl levels
11/17/2005WO2004078140A3 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
11/17/2005WO2004070006A3 Nucleic acid antigens embedded in thermoplastic
11/17/2005WO2004063331A9 SiRNA MEDIATED POST-TRANSRIPTIONAL GENE SILENCING OF GENES INVOLVED IN ALOPECIA
11/17/2005WO2004048534A3 Modulation of cytokine-inducible kinase expression
11/17/2005WO2003087321A8 Plant acyl-coa synthetases
11/17/2005WO2003068941A3 Modulation of immune response by non-peptide binding stress response polypeptides
11/17/2005WO2003042399A8 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
11/17/2005WO2001072768A8 Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same
11/17/2005WO2001065911A9 Improved poloxamer and poloxamine compositions for nucleic acid delivery
11/17/2005WO1997049725A9 Modified factor viii
11/17/2005US20050257298 Inbred corn line phace
11/17/2005US20050257297 Acala ULTIMA EF cultivar plant and seed
11/17/2005US20050257294 Generation of plants with improved drought tolerance
11/17/2005US20050257293 Biological containment system
11/17/2005US20050257292 Ehd1gene promoting plant flowering, and utlization thereof
11/17/2005US20050257291 Genes coding for a protein having a glycoside transfer activity
11/17/2005US20050257290 Nematode fatty acid desaturase-like sequences
11/17/2005US20050257289 AP2 domain transcription factor ODP2 (ovule development protein 2) and methods of use
11/17/2005US20050257288 Generation of plants with altered oil content
11/17/2005US20050257287 Vectors capable of imparting herbicide resistance and viral cross protection and methods
1 ... 1910 1911 1912 1913 1914 1915 1916 1917 1918 1919 1920 1921 1922 1923 1924 1925 1926 1927 1928 1929 1930 ... 4023